| 產品名稱 |
Bovine herpesvirus 1 |
| 商品貨號 |
B162998 |
| Classification |
Herpesviridae, Varicellovirus |
| Deposited As |
Infectious bovine rhinotracheitis virus |
| Agent |
Bovine herpesvirus 1 |
| Strain |
IBRV(NG)dltkdlgIII |
| Common Name |
Infectious bovine rhinotracheitis virus, Bovine rhinotracheitis virus |
| Applications |
An attenuated virus produced by recombinant technology that is TK and gIII negative. An attenuated virus produced by recombinant technology that is TK and gIII negative. |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
An attenuated virus produced by recombinant technology that is TK and gIII negative. Use BHV-negative FBS or lamb sera to supplement growth medium. |
| Effect on Host |
Cytopathic effects (typical herpesvirus CPE) |
| Recommended Host |
RAB-9 cells (ATCC CRL-1414) RAB-9 cells (ATCC CRL-1414); bovine embryo cells; bovine kidney cells; bovine turbinate cells |
| Growth Conditions |
Incubation: 3-4 days at 34.5°C |
| Name of Depositor |
S Kit |
| U.S. Patent |
|
| U.S. Patent Number |
|
| References |
Kit M, et al. Infectious bovine rhinotracheitis virus mutants, methods for the production of same and methods for the use of same. US Patent 4,992,051 dated Feb 12 1991
Kit M, et al. Infectious bovine rhinotrachetis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same. US Patent 5,128,129 dated Jul 7 1992
|
